• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在绵羊的胃肠道中,胰高血糖素样肽-1 及其受体与 GPR40 和胰岛素受体的信号关联。

The signalling association of glucagon-like peptide-1 and its receptors in the gastrointestinal tract and GPR40 and insulin receptor in the pancreas of sheep.

机构信息

Animal Physiology Division, ICAR-National Institute of Animal Nutrition and Physiology, Bangalore 560030, India.

Animal Nutrition Division, ICAR-National Institute of Animal Nutrition and Physiology, Bangalore 560030, India.

出版信息

Gen Comp Endocrinol. 2024 Nov 1;358:114602. doi: 10.1016/j.ygcen.2024.114602. Epub 2024 Sep 1.

DOI:10.1016/j.ygcen.2024.114602
PMID:39226991
Abstract

The present study was aimed at gaining insight into the signalling relationship between glucagon-like peptide-1 (GLP-1) and its receptor (GLP-1R) in the regulation of glucose metabolism. Further, to assess the role of G-protein-coupled receptor 40 (GPR40) and insulin receptor (INSR) in the pancreas of sheep that were supplemented with calcium salts of long-chain fatty acids (CSFAs). An experiment was carried out over a period of 60 days with eighteen sheep, and they were fed with a standard basal diet. The sheep were divided into three groups: CSFA0 (without CSFAs), while CSFA3 and CSFA5 were supplemented with 3 % and 5 % of CSFAs, respectively. Plasma concentrations of GLP-1, insulin, glucagon, and glucose were assessed every two weeks. At the end of the experiment, sheep were slaughtered, and samples of gastrointestinal tract (GIT) epithelial tissues and pancreas were collected to assess the relative expression of mRNA of GPR40, GLP-1R, and INSR. Postprandial GLP-1 and insulin were increased by 3.7-4.1 and 1.45-1.5 times, respectively, in the CSFAs-supplemented groups compared to CSFA0. Post-feeding, glucagon and glucose levels decreased in CSFA3 and CSFA5 compared to CSFA0. The results indicated that the supplementation of LCFAs increased the expression of GLP-1R in the GIT and pancreas, as well as the mRNA of GPR40 and INSR in the pancreas. Chemosensing of LCFAs by GPR40 in the pancreas triggers signalling transduction, and enhanced GLP-1 and GLP-1R resulted in moderately increased insulin secretion and reduced glucagon levels. These combined effects, along with the glucose-lowering effect of GLP-1, effectively lowered glucose levels in normoglycemic sheep.

摘要

本研究旨在深入了解胰高血糖素样肽-1(GLP-1)与其受体(GLP-1R)在葡萄糖代谢调节中的信号关系。此外,评估长链脂肪酸钙盐(CSFAs)补充后绵羊胰腺中 G 蛋白偶联受体 40(GPR40)和胰岛素受体(INSR)的作用。该实验在 60 天内对 18 只绵羊进行,它们喂食标准基础日粮。绵羊分为三组:CSFA0(无 CSFAs),CSFA3 和 CSFA5 分别补充 3%和 5%的 CSFAs。每两周评估一次 GLP-1、胰岛素、胰高血糖素和血糖的血浆浓度。实验结束时,宰杀绵羊,采集胃肠道(GIT)上皮组织和胰腺样本,评估 GPR40、GLP-1R 和 INSR 的相对 mRNA 表达。与 CSFA0 相比,CSFA 补充组餐后 GLP-1 和胰岛素分别增加了 3.7-4.1 倍和 1.45-1.5 倍。CSFA3 和 CSFA5 组餐后胰高血糖素和葡萄糖水平较 CSFA0 组降低。结果表明,LCFAs 的补充增加了 GIT 和胰腺中 GLP-1R 的表达,以及胰腺中 GPR40 和 INSR 的 mRNA 表达。GPR40 对 LCFAs 的化学感应触发信号转导,增强的 GLP-1 和 GLP-1R 导致胰岛素分泌适度增加和胰高血糖素水平降低。这些综合作用,加上 GLP-1 的降血糖作用,有效降低了正常血糖绵羊的血糖水平。

相似文献

1
The signalling association of glucagon-like peptide-1 and its receptors in the gastrointestinal tract and GPR40 and insulin receptor in the pancreas of sheep.在绵羊的胃肠道中,胰高血糖素样肽-1 及其受体与 GPR40 和胰岛素受体的信号关联。
Gen Comp Endocrinol. 2024 Nov 1;358:114602. doi: 10.1016/j.ygcen.2024.114602. Epub 2024 Sep 1.
2
Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.易患糖尿病大鼠肠道中的生物活性胰高血糖素样肽-1、胰腺中的受体表达以及对胰高血糖素样肽-1的胰岛素反应。
Endocrine. 2004 Feb;23(1):77-84. doi: 10.1385/ENDO:23:1:77.
3
Chemosensing of fat digestion by the expression pattern of GPR40, GPR120, CD36 and enteroendocrine profile in sheep.绵羊中 GPR40、GPR120、CD36 的表达模式和肠内分泌谱对脂肪消化的化学感应作用。
Res Vet Sci. 2022 Dec 5;150:89-97. doi: 10.1016/j.rvsc.2022.05.017. Epub 2022 Jul 1.
4
Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.新型 G 蛋白偶联受体 40 激动剂 DS-1558 与胰高血糖素样肽-1 受体激动剂联合增强胰岛素分泌和改善葡萄糖耐量。
Eur J Pharmacol. 2014 Aug 15;737:194-201. doi: 10.1016/j.ejphar.2014.05.014. Epub 2014 May 22.
5
Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.高脂喂养、胰岛素抵抗的小鼠中,中枢 GLP-1 受体的急性激活增强了肝脏的胰岛素作用和胰岛素分泌。
Am J Physiol Endocrinol Metab. 2012 Feb 1;302(3):E334-43. doi: 10.1152/ajpendo.00409.2011. Epub 2011 Nov 15.
6
Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.在胰高血糖素样肽-1(GLP-1)受体信号传导中断的小鼠中,鉴定对葡萄糖稳态至关重要的GLP-1作用。
Diabetes. 1998 Apr;47(4):632-9. doi: 10.2337/diabetes.47.4.632.
7
Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.人心外膜脂肪组织表达葡萄糖依赖性胰岛素促分泌多肽、胰高血糖素和胰高血糖素样肽-1 受体,作为多效治疗的潜在靶点。
Eur J Prev Cardiol. 2023 Jun 1;30(8):680-693. doi: 10.1093/eurjpc/zwad050.
8
Mercaptoacetate blocks fatty acid-induced GLP-1 secretion in male rats by directly antagonizing GPR40 fatty acid receptors.巯基乙酸盐通过直接拮抗GPR40脂肪酸受体来阻断雄性大鼠中脂肪酸诱导的胰高血糖素样肽-1分泌。
Am J Physiol Regul Integr Comp Physiol. 2016 Apr 15;310(8):R724-32. doi: 10.1152/ajpregu.00387.2015. Epub 2016 Jan 20.
9
Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.胰高血糖素样肽1受体基因敲除小鼠中葡萄糖依赖性促胰岛素多肽分泌增强及促胰岛素作用增强
Diabetes. 1998 Jul;47(7):1046-52. doi: 10.2337/diabetes.47.7.1046.
10
Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.在瘦素和胰高血糖素样肽-1(GLP-1)作用联合缺失的小鼠中,消除GLP-1受体信号不会改变体重增加和胰岛适应性。
Diabetes. 2000 Sep;49(9):1552-60. doi: 10.2337/diabetes.49.9.1552.